Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Addex Therapeutics Ltd    ADXN   CH0029850754

ADDEX THERAPEUTICS LTD (ADXN)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Swiss Exchange
07/11/2018 07/12/2018 07/13/2018 07/16/2018 07/17/2018 Date
2.54(c) 2.6(c) 2.54(c) 2.56(c) 2.56 Last
21 467 37 924 38 917 2 302 14 086 Volume
-3.79% +2.36% -2.31% +0.79% 0.00% Change
More quotes
Company
Addex Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of drugs for human health.It develops novel, orally available, and small molecule allosteric modulators for neurological disorders.The company was founded by Vincent Mutel, Timothy Dyer, and Mark Epping-Jordan... 
More about the company
Latest news on ADDEX THERAPEUTICS LTD
07/12ADDEX THERAPEUTICS : Van Leeuwenhoeck Issues Equity Research Note Highlighting A..
AQ
06/21ADDEX THERAPEUTICS : Shareholders Approve All Resolutions at Annual General Meet..
GL
04/30ADDEX THERAPEUTICS : Reports 2017 Full Year Results and Provides Corporate Updat..
GL
04/25ADDEX THERAPEUTICS LTD : annual earnings release
03/30ADDEX THERAPEUTICS : Sucessfully Raises CHF40 million in Capital Increase
AQ
03/29ADDEX THERAPEUTICS : Sucessfully Raises CHF40 million in Capital Increase
GL
03/29ADDEX THERAPEUTICS : Sucessfully Raises CHF40 million in Capital Increase
AQ
03/20ADDEX THERAPEUTICS : Swiss Takeover Board Validates New Article 39 (Opting-Out P..
GL
03/19ADDEX THERAPEUTICS : Shareholders Approved all Board Proposals at Extraordinary ..
GL
03/05ADDEX THERAPEUTICS : Secures Investor Commitment for CHF40 million Capital Incre..
GL
More news
Sector news : Biotechnology & Medical Research - NEC
07/09LONZA : restates 2017 figures after changing accounting standard
RE
07/03Sanofi beefs up diabetes pipeline to retrieve success
RE
06/29European stocks shrug off trade worries with quarterly gain
RE
06/29GILEAD SCIENCES : Rival Novartis, Gilead CAR-T therapies win European panel reco..
RE
06/20GILEAD SCIENCES : GSK takes billion-dollar drug fight with Gilead to top AIDS me..
RE
More sector news : Biotechnology & Medical Research - NEC
Latest Tweets
07/14Severe Thunderstorm Warning for Beckham, Custer, Dewey and Roger Mills County.. 
07/11Dine 909: Raising Cane’s opens at Ontario Mills, Roger’s Burgers lands in San.. 
07/06Severe Thunderstorm Warning for Roger Mills County until 3:30pm.  
07/04Craig was born in 1959 to Tina Turner and then-boyfriend Raymond Hill, a saxo..
34
06/301052p-30-45 mph wind gusts possible in parts of Woodward, Roger Mills, Beckha..
1
More tweets
Qtime:75
Chart ADDEX THERAPEUTICS LTD
Duration : Period :
Addex Therapeutics Ltd Technical Analysis Chart | ADXN | CH0029850754 | 4-Traders
Technical analysis trends ADDEX THERAPEUTICS LTD
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Managers
NameTitle
Timothy Dyer Chief Executive Officer & Director
Vincent M. Lawton Chairman
Roger G. Mills Director & Chief Medical Officer
Raymond George Hill Director
Jean-Philippe Rocher Head-Discovery
Sector and Competitors
1st jan.Capitalization (M$)
ADDEX THERAPEUTICS LTD11.79%90
CELLTRION, INC.--.--%31 997
IQVIA HOLDINGS INC10.00%22 131
LONZA GROUP9.53%21 465
INCYTE CORPORATION-25.89%14 878
SEATTLE GENETICS, INC.31.68%11 147